Table 1 The clinical baseline characteristics of the two groups.
Parameters | Total (n = 84) | ARgroup (n = 21) | AS group (n = 63) | P |
|---|---|---|---|---|
Age, (year) | 71.6 ± 7.0 | 69.4 ± 7.3 | 72.3 ± 6.8 | 0.408 |
Man, n (%) | 51(60.7) | 16(76.2) | 35(55.6) | 0.096 |
BMI, (kg/m2) | 22.6 ± 3.2 | 21.1 ± 3.3 | 23.1 ± 3.0 | 0.780 |
NYHA class, n (%) | 0.509 | |||
I-II | 8(9.5) | 1(4.8) | 7(11.1) | |
III | 58(69.0) | 15(71.4) | 43(68.3) | |
IV | 18(21.4) | 5(23.8) | 13(20.6) | |
STS score, (%) | 8.2 ± 3.6 | 6.9 ± 3.1 | 8.6 ± 3.7 | 0.906 |
Health history, n (%) | ||||
Smoking | 20(23.8) | 6(28.6) | 14(22.2) | 0.556 |
Hyperlipidemia | 2(2.4) | 0(0.0) | 2(3.2) | 0.113 |
Hypertension | 50(59.5) | 15(71.4) | 35(55.6) | 0.202 |
Diabetes | 13(15.5) | 1(4.8) | 12(19.0) | 0.119 |
Coronary heart disease | 23(27.4) | 5(23.8) | 18(28.6) | 0.674 |
Atrial fibrillation | 16(19.0) | 7(33.3) | 9(14.3) | 0.056 |
Cerebrovascular disease | 11(13.1) | 5(23.8) | 6(9.5) | 0.095 |
COPD | 9(10.7) | 3(14.3) | 6(9.5) | 0.544 |
CKD | 6(7.1) | 2(9.5) | 4(6.3) | 0.627 |
PH | 12(14.3) | 3(14.3) | 9(14.3) | > 0.999 |
PPM | 3(3.6) | 2(9.5) | 1(1.6) | 0.092 |
Other heart surgeries | 19(22.6) | 5(23.8) | 14(22.2) | 0.881 |
Type of valve, n (%) | < 0.001 | |||
BAV | 46(54.8) | 2(9.5) | 44(69.8) | |
TAV | 38(45.2) | 19(90.5) | 19(30.2) |
